Atropine's Trade-Off
Systematic review investigates dose-dependent effects of atropine on accommodative and binocular visual function
Clinical Scorecard: Atropine's Trade-Off
At a Glance
Category Detail
Condition Myopia control Key Mechanisms Dose-dependent effects of atropine on accommodative amplitude and binocular vision. Target Population Children and adolescents with myopia. Care Setting Ophthalmology clinics and practices.
Key Highlights
Atropine's effects on accommodation and binocular vision are dose dependent. 0.01% atropine shows minimal impact on accommodative amplitude and binocular vision. 0.05% atropine provides significant reduction in accommodative amplitude with long-lasting effects. Higher concentrations (0.1% and above) lead to dramatic accommodation losses exceeding 9 diopters. Individualized treatment is essential to balance myopia control and visual function. Guideline-Based Recommendations
Diagnosis
Assess accommodative amplitude and binocular vision before prescribing atropine. Management
Consider starting with 0.01% atropine for minimal impact on visual function. Monitoring & Follow-up
Regularly evaluate near visual performance and discuss symptoms with patients and parents. Risks
Higher concentrations of atropine may lead to significant visual impairment and discomfort. Patient & Prescribing Data
Children and adolescents with myopia requiring management.
0.05% atropine is effective for myopia control but may compromise visual function.
Clinical Best Practices
Individualize atropine dosing based on patient response and visual function. Incorporate accommodation and binocular vision assessments in routine evaluations. Consider near additions for patients experiencing near blur or eyestrain. Related Resources & Content
